Diagnostic Method For Determining The Presence And Amount Of Human Interleukin-3 In A Sample Using Novel Il-3 Antibodies

  • Published: Apr 10, 2018
  • Earliest Priority: May 29 2012
  • Family: 8
  • Cited Works: 39
  • Cited by: 0
  • Cites: 8
  • Sequences: 2
  • Additional Info: Cited Works Sequence

The full document isn't yet available to us from the patent office.


For determining the presence and amount of human interleukin 3 (IL-3) in a sample, the present invention provides a diagnostic method, wherein an anti-IL-3-antibody, fragment or construct thereof is added to said sample under conditions which allow for binding said antibody, fragment or construct thereof to IL-3 and detecting the amount of antibody bound IL-3 in said sample, wherein the anti-IL-3-antibody is clone 13. Further subject matter of the present invention are the novel antibody clone 13, a nucleic acid encoding said antibody and a hybridoma cell line which produces antibody clone 13. A diagnostic assay kit contains all necessary reagents and materials for performing such assay, preferably an ELISA assay and especially preferably contains antibody clones 13 and 11.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Apr 10, 2018
  • Application: Jun 19, 2017
    US US 201715626812 A
  • Priority: Jun 19, 2017
    US US 201715626812 A
  • Priority: Nov 13, 2014
    US US 201414400958 A
  • Priority: May 29, 2013
    EP EP 2013061122 W
  • Priority: May 29, 2012
    EP EP 12169805 A

Download Citation

Sign in to the Lens